aluates Reports

$ 0.0

Automative

Idiopathic Pulmonary Fibrosis Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-23U12572

Global Idiopathic Pulmonary Fibrosis Treatment Drug Market Research Report 2022

BUY CHAPTERS

Idiopathic Pulmonary Fibrosis Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23U12572

Report

December 2024

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Roche Holding AG

Idiopathic Pulmonary Fibrosis Treatment Drug - Market Size

The global market for Idiopathic Pulmonary Fibrosis Treatment Drug was estimated to be worth US$ 336 million in 2023 and is forecast to a readjusted size of US$ 571.3 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Idiopathic Pulmonary Fibrosis Treatment Drug - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Idiopathic Pulmonary Fibrosis Treatment Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Idiopathic Pulmonary Fibrosis Treatment Drug by region & country, by Type, and by Application.

The Idiopathic Pulmonary Fibrosis Treatment Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idiopathic Pulmonary Fibrosis Treatment Drug.

Market Segmentation

Scope of Idiopathic Pulmonary Fibrosis Treatment Drug - Market Report

Report Metric	Details
Report Name	Idiopathic Pulmonary Fibrosis Treatment Drug - Market
Forecasted market size in 2030	US$ 571.3 million
CAGR	8.0%
Forecasted years	2024 - 2030
Segment by Type:	Nintedanib Pirfenidone
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Holding AG, Boehringer Ingelheim International GmbH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Idiopathic Pulmonary Fibrosis Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Idiopathic Pulmonary Fibrosis Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Idiopathic Pulmonary Fibrosis Treatment Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Idiopathic Pulmonary Fibrosis Treatment Drug - Market size in 2030?

Ans: The Idiopathic Pulmonary Fibrosis Treatment Drug - Market size in 2030 will be US$ 571.3 million.

Who are the main players in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report?

Ans: The main players in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market are Roche Holding AG, Boehringer Ingelheim International GmbH

What are the Application segmentation covered in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report?

Ans: The Applications covered in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report are Hospital, Clinic

What are the Type segmentation covered in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report?

Ans: The Types covered in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report are Nintedanib, Pirfenidone

1 Market Overview

1.1 Idiopathic Pulmonary Fibrosis Treatment Drug Product Introduction

1.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Market Size Forecast

1.2.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030)

1.2.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume (2019-2030)

1.2.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Price (2019-2030)

1.3 Idiopathic Pulmonary Fibrosis Treatment Drug Market Trends & Drivers

1.3.1 Idiopathic Pulmonary Fibrosis Treatment Drug Industry Trends

1.3.2 Idiopathic Pulmonary Fibrosis Treatment Drug Market Drivers & Opportunity

1.3.3 Idiopathic Pulmonary Fibrosis Treatment Drug Market Challenges

1.3.4 Idiopathic Pulmonary Fibrosis Treatment Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Players Revenue Ranking (2023)

2.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Revenue by Company (2019-2024)

2.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Players Sales Volume Ranking (2023)

2.4 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Company Players (2019-2024)

2.5 Global Idiopathic Pulmonary Fibrosis Treatment Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Idiopathic Pulmonary Fibrosis Treatment Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Idiopathic Pulmonary Fibrosis Treatment Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Idiopathic Pulmonary Fibrosis Treatment Drug

2.9 Idiopathic Pulmonary Fibrosis Treatment Drug Market Competitive Analysis

2.9.1 Idiopathic Pulmonary Fibrosis Treatment Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Idiopathic Pulmonary Fibrosis Treatment Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Pulmonary Fibrosis Treatment Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Nintedanib

3.1.2 Pirfenidone

3.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type

3.2.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, by Type (2019-2030)

3.2.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Type

3.3.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Idiopathic Pulmonary Fibrosis Treatment Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application

4.2.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, by Application (2019-2030)

4.2.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Application

4.3.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Idiopathic Pulmonary Fibrosis Treatment Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region

5.1.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (2019-2024)

5.1.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (2025-2030)

5.1.4 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (%), (2019-2030)

5.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region

5.2.1 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (2019-2024)

5.2.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (2025-2030)

5.2.4 Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Idiopathic Pulmonary Fibrosis Treatment Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

5.4.2 North America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

5.5.2 Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

5.7.2 South America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value

6.2.1 Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.3.2 United States Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.4.2 Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.5.2 China Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.6.2 Japan Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.7.2 South Korea Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019-2030

6.9.2 India Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche Holding AG

7.1.1 Roche Holding AG Company Information

7.1.2 Roche Holding AG Introduction and Business Overview

7.1.3 Roche Holding AG Idiopathic Pulmonary Fibrosis Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Roche Holding AG Idiopathic Pulmonary Fibrosis Treatment Drug Product Offerings

7.1.5 Roche Holding AG Recent Development

7.2 Boehringer Ingelheim International GmbH

7.2.1 Boehringer Ingelheim International GmbH Company Information

7.2.2 Boehringer Ingelheim International GmbH Introduction and Business Overview

7.2.3 Boehringer Ingelheim International GmbH Idiopathic Pulmonary Fibrosis Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boehringer Ingelheim International GmbH Idiopathic Pulmonary Fibrosis Treatment Drug Product Offerings

7.2.5 Boehringer Ingelheim International GmbH Recent Development

8 Industry Chain Analysis

8.1 Idiopathic Pulmonary Fibrosis Treatment Drug Industrial Chain

8.2 Idiopathic Pulmonary Fibrosis Treatment Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Idiopathic Pulmonary Fibrosis Treatment Drug Sales Model

8.5.2 Sales Channel

8.5.3 Idiopathic Pulmonary Fibrosis Treatment Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Roche Holding AG

List of Tables

Table 1. Idiopathic Pulmonary Fibrosis Treatment Drug Market Trends

Table 2. Idiopathic Pulmonary Fibrosis Treatment Drug Market Drivers & Opportunity

Table 3. Idiopathic Pulmonary Fibrosis Treatment Drug Market Challenges

Table 4. Idiopathic Pulmonary Fibrosis Treatment Drug Market Restraints

Table 5. Global Idiopathic Pulmonary Fibrosis Treatment Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Idiopathic Pulmonary Fibrosis Treatment Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Idiopathic Pulmonary Fibrosis Treatment Drug Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Idiopathic Pulmonary Fibrosis Treatment Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Idiopathic Pulmonary Fibrosis Treatment Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Idiopathic Pulmonary Fibrosis Treatment Drug

Table 13. Global Idiopathic Pulmonary Fibrosis Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Pulmonary Fibrosis Treatment Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Idiopathic Pulmonary Fibrosis Treatment Drug Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Idiopathic Pulmonary Fibrosis Treatment Drug Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Idiopathic Pulmonary Fibrosis Treatment Drug Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Idiopathic Pulmonary Fibrosis Treatment Drug Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Idiopathic Pulmonary Fibrosis Treatment Drug Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Idiopathic Pulmonary Fibrosis Treatment Drug Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Roche Holding AG Company Information

Table 58. Roche Holding AG Introduction and Business Overview

Table 59. Roche Holding AG Idiopathic Pulmonary Fibrosis Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Roche Holding AG Idiopathic Pulmonary Fibrosis Treatment Drug Product Offerings

Table 61. Roche Holding AG Recent Development

Table 62. Boehringer Ingelheim International GmbH Company Information

Table 63. Boehringer Ingelheim International GmbH Introduction and Business Overview

Table 64. Boehringer Ingelheim International GmbH Idiopathic Pulmonary Fibrosis Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Boehringer Ingelheim International GmbH Idiopathic Pulmonary Fibrosis Treatment Drug Product Offerings

Table 66. Boehringer Ingelheim International GmbH Recent Development

Table 67. Key Raw Materials Lists

Table 68. Raw Materials Key Suppliers Lists

Table 69. Idiopathic Pulmonary Fibrosis Treatment Drug Downstream Customers

Table 70. Idiopathic Pulmonary Fibrosis Treatment Drug Distributors List

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Idiopathic Pulmonary Fibrosis Treatment Drug Product Picture

Figure 2. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Price (2019-2030) & (US$/Unit)

Figure 6. Idiopathic Pulmonary Fibrosis Treatment Drug Report Years Considered

Figure 7. Global Idiopathic Pulmonary Fibrosis Treatment Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Idiopathic Pulmonary Fibrosis Treatment Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Idiopathic Pulmonary Fibrosis Treatment Drug Revenue in 2023

Figure 10. Idiopathic Pulmonary Fibrosis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Nintedanib Picture

Figure 12. Pirfenidone Picture

Figure 13. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Idiopathic Pulmonary Fibrosis Treatment Drug Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinic

Figure 20. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Idiopathic Pulmonary Fibrosis Treatment Drug Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Idiopathic Pulmonary Fibrosis Treatment Drug Sales Volume (%), (2019-2030)

Figure 37. United States Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 43. China Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 45. China Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 55. India Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Type (%), 2023 VS 2030

Figure 57. India Idiopathic Pulmonary Fibrosis Treatment Drug Sales Value by Application (%), 2023 VS 2030

Figure 58. Idiopathic Pulmonary Fibrosis Treatment Drug Industrial Chain

Figure 59. Idiopathic Pulmonary Fibrosis Treatment Drug Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Idiopathic Pulmonary Fibrosis IPF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cystic Fibrosis Therapeutics Market Research Report 2025

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Therapy Drug Market Research Report 2025

Global Autoimmune Diseases Treatment Market Research Report 2024

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2J9266

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Embolization Particle Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-33P8693

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Ampicillin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-9P9060

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Autism Spectrum Disorder Educational Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18B19448

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Idiopathic Pulmonary Fibrosis Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-23U12572

Idiopathic Pulmonary Fibrosis Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Idiopathic Pulmonary Fibrosis Treatment Drug - Market Size

Idiopathic Pulmonary Fibrosis Treatment Drug - Market

Report Scope

Scope of Idiopathic Pulmonary Fibrosis Treatment Drug - Market Report

Chapter Outline

FAQ for this report

What is the Idiopathic Pulmonary Fibrosis Treatment Drug - Market size in 2030?

Who are the main players in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report?

What are the Application segmentation covered in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report?

What are the Type segmentation covered in the Idiopathic Pulmonary Fibrosis Treatment Drug - Market report?

FEATURED COMPANIES

RELATED REPORTS